A new study warns that combining aspirin with blood thinners like Pradaxa, Xarelto and Eliquis provides few benefits and may increase bleeding risks,
A new study indicates Xarelto carries greater risks of bleeding events and death for recent heart valve replacement patients.
A proposed $775 million settlement agreement could resolve nearly all outstanding Xarelto bleeding injury lawsuits.
A new study indicates that the Xarelto and Eliquis reversal agent Andexxa restores 82% of patients to excellent or good hemostasis following a major bleeding event caused by the blood…
The FDA has approved Andexxa, a reversal agent for Xarelto and Eliquis, for large-scale production in the face of growing bleeding injury reports.
Boehringer-Ingelheim has been ordered to pay $1.25 million to the family of a woman who died of Pradaxa gastrointestinal bleeding side effects.
A new study found that Xarelto failed to prevent deaths from heart disease and heart failure.
A new study finds that Xarelto appears to be relatively ineffective in preventing blood clot-related problems in recently hospitalized patients.
A new study warns that Xarelto may carry three times the risk of brain bleeds when compared to aspirin.
A hearing today will determine whether an appeals court could hear arguments indicating that Xarelto lawsuits are preempted by federal law.
